Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start
source: pixabay.com

Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start

Editor’s Choice: A Biomarker for Early Alzheimer’s Detection, A Teen Living with Usher Syndrome, and A Possible Chagas Disease Treatment

Happy Monday! This week, we have details on a method for detecting Alzheimer's 17 years in advance, the story of a teen living with Usher syndrome, and a possible breakthrough…

Continue Reading Editor’s Choice: A Biomarker for Early Alzheimer’s Detection, A Teen Living with Usher Syndrome, and A Possible Chagas Disease Treatment
Alzheimer’s Disease: Study Suggests a Connection Between Digestive Disorders and AD
source: pixabay.com

Alzheimer’s Disease: Study Suggests a Connection Between Digestive Disorders and AD

  The gut-brain axis has recently been mentioned in connection with various disorders. According to an article in SciTechDaily, a study at ECU’s Centre for Precision Health confirms a genetic…

Continue Reading Alzheimer’s Disease: Study Suggests a Connection Between Digestive Disorders and AD

Alzheimer’s: German and UK Scientists Successfully Reduced Alzheimer’s Symptoms in Laboratory Animals

  Eureka Alert recently published a statement by a team of researchers that early results of a new method of treating Alzheimer’s have been “absolutely spectacular.” The new antibody-based therapy…

Continue Reading Alzheimer’s: German and UK Scientists Successfully Reduced Alzheimer’s Symptoms in Laboratory Animals
Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?
source: pixabay.com

Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?

  When you are looking for new treatments that will either stop or slow the development of Alzheimer’s disease, where would you look? According to a recent article in Gladstone…

Continue Reading Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?
 Scientists Announce Breakthrough Discovery for Alzheimer’s and Other Neurological Diseases
source: pixabay.com

 Scientists Announce Breakthrough Discovery for Alzheimer’s and Other Neurological Diseases

   The Times Now News recently featured an article that highlighted a study by a group of NYU Langone scientists. The study paper was published October 6th, 2021 in the…

Continue Reading  Scientists Announce Breakthrough Discovery for Alzheimer’s and Other Neurological Diseases
Two Decades of Research May Be Reversed by a New Alzheimer’s Discovery
source: pixabay.com

Two Decades of Research May Be Reversed by a New Alzheimer’s Discovery

Alois Alzheimer, a clinical psychiatrist and expert in the study of the nervous system, reported a disease process of the cerebral cortex. The year was 1906. We are approaching July…

Continue Reading Two Decades of Research May Be Reversed by a New Alzheimer’s Discovery
Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.
source: pixabay.com

Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.

  The pressure was on. Researchers had been studying Alzheimer’s for decades. Every morsel of discovery was hailed as moving closer to a cure and results were always expected soon…

Continue Reading Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.
FDA Approves New Alzheimer’s Drug, But Not Without Controversy
source: pixabay.com

FDA Approves New Alzheimer’s Drug, But Not Without Controversy

According to an announcement from the US Food and Drug Administration (FDA), the agency has recently approved a new therapy for Alzheimer's disease. While this is a significant moment for…

Continue Reading FDA Approves New Alzheimer’s Drug, But Not Without Controversy

Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases

In the last decade, scientists have made great strides in uncovering details of the underlying causes of neurodegenerative diseases. It is only a matter of time that treatment and prevention…

Continue Reading Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases
LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation
Thor_Deichmann / Pixabay

LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation

  In a recent press release, biotechnology and gene therapy company LEXEO Therapeutics ("LEXEO") shared that its gene therapy LX1001 received Fast Track designation from the FDA. Overall, LX1001 is…

Continue Reading LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation
A First: Human Clinical Trial Assessing Gene Therapy for Alzheimer’s Disease
source: pixabay.com

A First: Human Clinical Trial Assessing Gene Therapy for Alzheimer’s Disease

Billions of dollars have been spent in research over decades, resulting in only two therapies that treat symptoms of Alzheimer’s disease (AD). There are no approved methods that diminish the…

Continue Reading A First: Human Clinical Trial Assessing Gene Therapy for Alzheimer’s Disease
Five Genes Identified That May Cause Lewy Body Dementia
source: pixabay.com

Five Genes Identified That May Cause Lewy Body Dementia

According to a recent press release, scientists studying the Uniformed Services University of the Health Sciences' (USU) The American Genome Center (TAGC) identified five genes which could play a role…

Continue Reading Five Genes Identified That May Cause Lewy Body Dementia
Each New Discovery Brings Scientists Closer to Finding the Cause of Alzheimer’s Disease
source: pixabay.com

Each New Discovery Brings Scientists Closer to Finding the Cause of Alzheimer’s Disease

Scientists are researching Alzheimer’s disease (AD) from all angles and gradually closing in on the cause of the disease. According to an article in Neuroscience News, a discovery by researchers…

Continue Reading Each New Discovery Brings Scientists Closer to Finding the Cause of Alzheimer’s Disease
Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease
source: pixabay.com

Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease

Improving cognition and identifying abnormal molecular pathways in Alzheimer’s disease has been challenging. Current studies of Alzheimer’s disease have focused on reducing such occurrences as amyloid plaque, neuroinflammation, and neurofibrillary…

Continue Reading Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease
Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
source: pixabay.com

Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease

  There are many common elements in Alzheimer’s disease (AD), which is the most common type of dementia. It is now evident that there are varied spans of disease progression…

Continue Reading Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
These Alzheimer’s Patients Keep Their Memory
source: pixabay.com

These Alzheimer’s Patients Keep Their Memory

As reported in Newswise; 40% of people with primary progressive aphasia, a rare neurological disorder causing progressive language loss, also have underlying Alzheimer’s disease. However, while Alzheimer’s disease is characterized…

Continue Reading These Alzheimer’s Patients Keep Their Memory

Why The FDA Cautions Rare Neurological Disease Patients About Dental Amalgams

In a press release from the FDA; the FDA has new recommendations for a common mercury-based filling, dental amalgams. While the mercury in the tooth treatment isn't significant enough to…

Continue Reading Why The FDA Cautions Rare Neurological Disease Patients About Dental Amalgams
New Discovery Allows Researchers to Study Mechanisms in Neurodegenerative Diseases from Beginning of life
source: pixabay.com

New Discovery Allows Researchers to Study Mechanisms in Neurodegenerative Diseases from Beginning of life

Dilated cardiomyopathy is a heart condition caused by a mutation in the RBM20 gene. This heart condition is unique because it can affect young adults. These individuals are at an…

Continue Reading New Discovery Allows Researchers to Study Mechanisms in Neurodegenerative Diseases from Beginning of life
Researchers Have Discovered a New Molecular Mechanism in Alzheimer’s Disease
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Researchers Have Discovered a New Molecular Mechanism in Alzheimer’s Disease

At the Tufts University School of Medicine, researchers have uncovered a molecular mechanism that eventually leads to a build-up of amyloid beta, which is a major cause of Alzheimer's disease.…

Continue Reading Researchers Have Discovered a New Molecular Mechanism in Alzheimer’s Disease